Investor
Disease detection company Cardiosense, sustainable pill bottle maker Cabinet Health, testing company LumiraDx and physician engagement platform KeyOps also garner investments.
The deal is expected to close in January 2023.
According to TechCrunch and Fierce Healthcare, the health data company also recently closed a $200 million structured equity infusion.
The Mobile Health Apps tool aims to help developers determine which federal laws apply and which agencies oversee different aspects of mobile health technology.
The tool embeds in the EHR and allows providers to write care workflows that deliver best practices and next steps.
The company will use the investment to expand its technology's current abilities, add capabilities to detect additional health conditions and drive global growth.
Earlier this year, the company received FDA clearance for its RPM system that collects data like skin temperature, auscultation and heart rate in the home.
Though funding has fallen this year, Dr. Sunny Kumar, partner at GSR Ventures, said there are still opportunities for startups that can prove their value.
The startup has set up a subsidiary in New York using the proceeds from its first Series C round.
Former CEO Elizabeth Holmes was sentenced to more than 11 years in prison last month.